[
  {
    "image_type": "western_blot",
    "experiment_id": "IF-20251016-763",
    "experiment_type": "Western Blot",
    "cell_line": "HeLa",
    "target_protein": "p21",
    "target_mw": "21 kDa",
    "target_function": "Cell cycle inhibitor",
    "treatment": "Erlotinib",
    "treatment_target": "EGFR",
    "concentration": "500nM",
    "conditions": {
      "drug": "Erlotinib",
      "concentration": "500nM",
      "time": "6h",
      "replicates": 2
    },
    "outcome": "dose_dependent",
    "protocol": "Standard Western protocol with 10% SDS-PAGE, transfer to PVDF, primary antibody 1:1000, HRP-secondary 1:5000",
    "notes": "Dose-dependent inhibition of p21. IC50 approximately 500nM. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.77,
    "num_lanes": 6,
    "experiment_date": "2025-02-16",
    "acquisition_date": "2025-02-17 17:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_001.png",
    "filename": "western_blot_001.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "FC-20251230-930",
    "experiment_type": "Western Blot",
    "cell_line": "K562",
    "target_protein": "total AKT",
    "target_mw": "60 kDa",
    "target_function": "Kinase",
    "treatment": "Sorafenib",
    "treatment_target": "VEGFR/RAF",
    "concentration": "5\u03bcM",
    "conditions": {
      "drug": "Sorafenib",
      "concentration": "5\u03bcM",
      "time": "6h",
      "replicates": 4
    },
    "outcome": "dose_dependent",
    "protocol": "Standard Western protocol with 12% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:1000, HRP-secondary 1:5000",
    "notes": "Dose-dependent inhibition of total AKT. IC50 approximately 500nM. Loading control (GAPDH) unchanged.",
    "quality_score": 0.71,
    "num_lanes": 6,
    "experiment_date": "2025-10-03",
    "acquisition_date": "2025-10-04 23:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_002.png",
    "filename": "western_blot_002.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "FC-20250806-060",
    "experiment_type": "Western Blot",
    "cell_line": "MCF7",
    "target_protein": "BAX",
    "target_mw": "21 kDa",
    "target_function": "Pro-apoptotic",
    "treatment": "Lapatinib",
    "treatment_target": "HER2/EGFR",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Lapatinib",
      "concentration": "1\u03bcM",
      "time": "48h",
      "replicates": 3
    },
    "outcome": "dose_dependent",
    "protocol": "Standard Western protocol with 10% SDS-PAGE, transfer to PVDF, primary antibody 1:1000, HRP-secondary 1:5000",
    "notes": "Dose-dependent inhibition of BAX. IC50 approximately 500nM. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.76,
    "num_lanes": 6,
    "experiment_date": "2025-07-20",
    "acquisition_date": "2025-07-22 18:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_003.png",
    "filename": "western_blot_003.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "EXP-20250814-361",
    "experiment_type": "Western Blot",
    "cell_line": "MCF7",
    "target_protein": "pAKT (S473)",
    "target_mw": "60 kDa",
    "target_function": "PI3K signaling",
    "treatment": "Nilotinib",
    "treatment_target": "BCR-ABL",
    "concentration": "500nM",
    "conditions": {
      "drug": "Nilotinib",
      "concentration": "500nM",
      "time": "12h",
      "replicates": 2
    },
    "outcome": "inconclusive",
    "protocol": "Standard Western protocol with 10% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:2000, HRP-secondary 1:5000",
    "notes": "Results inconclusive. High background noise. Recommend optimizing blocking conditions. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.78,
    "num_lanes": 6,
    "experiment_date": "2025-02-28",
    "acquisition_date": "2025-03-02 11:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_004.png",
    "filename": "western_blot_004.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "FC-20250622-857",
    "experiment_type": "Western Blot",
    "cell_line": "A549",
    "target_protein": "cleaved PARP",
    "target_mw": "89 kDa",
    "target_function": "Apoptosis marker",
    "treatment": "Nilotinib",
    "treatment_target": "BCR-ABL",
    "concentration": "500nM",
    "conditions": {
      "drug": "Nilotinib",
      "concentration": "500nM",
      "time": "6h",
      "replicates": 3
    },
    "outcome": "inconclusive",
    "protocol": "Standard Western protocol with 8% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:2000, HRP-secondary 1:5000",
    "notes": "Results inconclusive. High background noise. Recommend optimizing blocking conditions. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.93,
    "num_lanes": 6,
    "experiment_date": "2025-07-29",
    "acquisition_date": "2025-07-31 12:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_005.png",
    "filename": "western_blot_005.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "EXP-20251013-171",
    "experiment_type": "Western Blot",
    "cell_line": "HEK293",
    "target_protein": "BAX",
    "target_mw": "21 kDa",
    "target_function": "Pro-apoptotic",
    "treatment": "Nilotinib",
    "treatment_target": "BCR-ABL",
    "concentration": "500nM",
    "conditions": {
      "drug": "Nilotinib",
      "concentration": "500nM",
      "time": "24h",
      "replicates": 2
    },
    "outcome": "inconclusive",
    "protocol": "Standard Western protocol with 8% SDS-PAGE, transfer to PVDF, primary antibody 1:1000, HRP-secondary 1:5000",
    "notes": "Results inconclusive. High background noise. Recommend optimizing blocking conditions. Loading control (GAPDH) unchanged.",
    "quality_score": 0.91,
    "num_lanes": 6,
    "experiment_date": "2025-10-19",
    "acquisition_date": "2025-10-21 15:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_006.png",
    "filename": "western_blot_006.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "WB-20250909-092",
    "experiment_type": "Western Blot",
    "cell_line": "HCC827",
    "target_protein": "p21",
    "target_mw": "21 kDa",
    "target_function": "Cell cycle inhibitor",
    "treatment": "Staurosporine",
    "treatment_target": "Pan-kinase",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Staurosporine",
      "concentration": "1\u03bcM",
      "time": "12h",
      "replicates": 2
    },
    "outcome": "dose_dependent",
    "protocol": "Standard Western protocol with 10% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:2000, HRP-secondary 1:5000",
    "notes": "Dose-dependent inhibition of p21. IC50 approximately 10nM. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.77,
    "num_lanes": 6,
    "experiment_date": "2025-12-23",
    "acquisition_date": "2025-12-24 13:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_007.png",
    "filename": "western_blot_007.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "FC-20260128-788",
    "experiment_type": "Western Blot",
    "cell_line": "HCC827",
    "target_protein": "cleaved Caspase-3",
    "target_mw": "17 kDa",
    "target_function": "Apoptosis",
    "treatment": "Crizotinib",
    "treatment_target": "ALK/MET",
    "concentration": "250nM",
    "conditions": {
      "drug": "Crizotinib",
      "concentration": "250nM",
      "time": "12h",
      "replicates": 2
    },
    "outcome": "negative",
    "protocol": "Standard Western protocol with 8% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:500, HRP-secondary 1:5000",
    "notes": "No significant change in cleaved Caspase-3 levels observed. Consider repeating with higher drug concentration. Loading control (GAPDH) unchanged.",
    "quality_score": 0.75,
    "num_lanes": 6,
    "experiment_date": "2025-04-09",
    "acquisition_date": "2025-04-11 07:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_008.png",
    "filename": "western_blot_008.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "IF-20250315-866",
    "experiment_type": "Western Blot",
    "cell_line": "A431",
    "target_protein": "GAPDH",
    "target_mw": "37 kDa",
    "target_function": "Loading control",
    "treatment": "Trametinib",
    "treatment_target": "MEK1/2",
    "concentration": "100nM",
    "conditions": {
      "drug": "Trametinib",
      "concentration": "100nM",
      "time": "72h",
      "replicates": 3
    },
    "outcome": "dose_dependent",
    "protocol": "Standard Western protocol with 12% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:2000, HRP-secondary 1:5000",
    "notes": "Dose-dependent inhibition of GAPDH. IC50 approximately 10nM. Loading control (GAPDH) unchanged.",
    "quality_score": 0.9,
    "num_lanes": 6,
    "experiment_date": "2025-04-10",
    "acquisition_date": "2025-04-11 19:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_009.png",
    "filename": "western_blot_009.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "EXP-20250704-756",
    "experiment_type": "Western Blot",
    "cell_line": "PC3",
    "target_protein": "cleaved PARP",
    "target_mw": "89 kDa",
    "target_function": "Apoptosis marker",
    "treatment": "Erlotinib",
    "treatment_target": "EGFR",
    "concentration": "500nM",
    "conditions": {
      "drug": "Erlotinib",
      "concentration": "500nM",
      "time": "12h",
      "replicates": 4
    },
    "outcome": "inconclusive",
    "protocol": "Standard Western protocol with 10% SDS-PAGE, transfer to PVDF, primary antibody 1:1000, HRP-secondary 1:5000",
    "notes": "Results inconclusive. High background noise. Recommend optimizing blocking conditions. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.96,
    "num_lanes": 6,
    "experiment_date": "2025-05-27",
    "acquisition_date": "2025-05-28 14:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_010.png",
    "filename": "western_blot_010.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "EXP-20250717-360",
    "experiment_type": "Western Blot",
    "cell_line": "Jurkat",
    "target_protein": "total AKT",
    "target_mw": "60 kDa",
    "target_function": "Kinase",
    "treatment": "Sorafenib",
    "treatment_target": "VEGFR/RAF",
    "concentration": "5\u03bcM",
    "conditions": {
      "drug": "Sorafenib",
      "concentration": "5\u03bcM",
      "time": "6h",
      "replicates": 4
    },
    "outcome": "inconclusive",
    "protocol": "Standard Western protocol with 10% SDS-PAGE, transfer to PVDF, primary antibody 1:500, HRP-secondary 1:5000",
    "notes": "Results inconclusive. High background noise. Recommend optimizing blocking conditions. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.81,
    "num_lanes": 6,
    "experiment_date": "2026-01-13",
    "acquisition_date": "2026-01-14 12:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_011.png",
    "filename": "western_blot_011.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "GEL-20250713-084",
    "experiment_type": "Western Blot",
    "cell_line": "U2OS",
    "target_protein": "\u03b2-actin",
    "target_mw": "42 kDa",
    "target_function": "Loading control",
    "treatment": "DMSO",
    "treatment_target": "Vehicle control",
    "concentration": "0.1%",
    "conditions": {
      "drug": "DMSO",
      "concentration": "0.1%",
      "time": "12h",
      "replicates": 3
    },
    "outcome": "negative",
    "protocol": "Standard Western protocol with 8% SDS-PAGE, transfer to PVDF, primary antibody 1:1000, HRP-secondary 1:5000",
    "notes": "No significant change in \u03b2-actin levels observed. Consider repeating with higher drug concentration. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.97,
    "num_lanes": 6,
    "experiment_date": "2025-06-30",
    "acquisition_date": "2025-07-01 07:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_012.png",
    "filename": "western_blot_012.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "GEL-20250713-256",
    "experiment_type": "Western Blot",
    "cell_line": "U2OS",
    "target_protein": "BCL-2",
    "target_mw": "26 kDa",
    "target_function": "Anti-apoptotic",
    "treatment": "Lapatinib",
    "treatment_target": "HER2/EGFR",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Lapatinib",
      "concentration": "1\u03bcM",
      "time": "12h",
      "replicates": 4
    },
    "outcome": "positive",
    "protocol": "Standard Western protocol with 8% SDS-PAGE, transfer to PVDF, primary antibody 1:500, HRP-secondary 1:5000",
    "notes": "Clear BCL-2 band detected at expected MW (26 kDa). Lapatinib treatment shows dose-dependent effect. Loading control (GAPDH) unchanged.",
    "quality_score": 0.85,
    "num_lanes": 6,
    "experiment_date": "2025-02-24",
    "acquisition_date": "2025-02-25 02:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_013.png",
    "filename": "western_blot_013.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "EXP-20250310-183",
    "experiment_type": "Western Blot",
    "cell_line": "Jurkat",
    "target_protein": "BCL-2",
    "target_mw": "26 kDa",
    "target_function": "Anti-apoptotic",
    "treatment": "Gefitinib",
    "treatment_target": "EGFR",
    "concentration": "100nM",
    "conditions": {
      "drug": "Gefitinib",
      "concentration": "100nM",
      "time": "12h",
      "replicates": 3
    },
    "outcome": "negative",
    "protocol": "Standard Western protocol with 8% SDS-PAGE, transfer to PVDF, primary antibody 1:500, HRP-secondary 1:5000",
    "notes": "No significant change in BCL-2 levels observed. Consider repeating with higher drug concentration. Loading control (GAPDH) unchanged.",
    "quality_score": 0.91,
    "num_lanes": 6,
    "experiment_date": "2025-04-14",
    "acquisition_date": "2025-04-15 13:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_014.png",
    "filename": "western_blot_014.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "FC-20250902-152",
    "experiment_type": "Western Blot",
    "cell_line": "HCC827",
    "target_protein": "pERK1/2 (T202/Y204)",
    "target_mw": "42 kDa",
    "target_function": "MAPK signaling",
    "treatment": "Nilotinib",
    "treatment_target": "BCR-ABL",
    "concentration": "500nM",
    "conditions": {
      "drug": "Nilotinib",
      "concentration": "500nM",
      "time": "24h",
      "replicates": 3
    },
    "outcome": "dose_dependent",
    "protocol": "Standard Western protocol with 8% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:500, HRP-secondary 1:5000",
    "notes": "Dose-dependent inhibition of pERK1/2 (T202/Y204). IC50 approximately 500nM. Loading control (GAPDH) unchanged.",
    "quality_score": 0.71,
    "num_lanes": 6,
    "experiment_date": "2026-01-22",
    "acquisition_date": "2026-01-23 18:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_015.png",
    "filename": "western_blot_015.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "EXP-20250717-449",
    "experiment_type": "Western Blot",
    "cell_line": "U2OS",
    "target_protein": "cleaved PARP",
    "target_mw": "89 kDa",
    "target_function": "Apoptosis marker",
    "treatment": "Crizotinib",
    "treatment_target": "ALK/MET",
    "concentration": "250nM",
    "conditions": {
      "drug": "Crizotinib",
      "concentration": "250nM",
      "time": "48h",
      "replicates": 3
    },
    "outcome": "negative",
    "protocol": "Standard Western protocol with 10% SDS-PAGE, transfer to PVDF, primary antibody 1:500, HRP-secondary 1:5000",
    "notes": "No significant change in cleaved PARP levels observed. Consider repeating with higher drug concentration. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.87,
    "num_lanes": 6,
    "experiment_date": "2025-06-12",
    "acquisition_date": "2025-06-13 02:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_016.png",
    "filename": "western_blot_016.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "EXP-20250209-208",
    "experiment_type": "Western Blot",
    "cell_line": "A549",
    "target_protein": "cleaved Caspase-3",
    "target_mw": "17 kDa",
    "target_function": "Apoptosis",
    "treatment": "Gefitinib",
    "treatment_target": "EGFR",
    "concentration": "100nM",
    "conditions": {
      "drug": "Gefitinib",
      "concentration": "100nM",
      "time": "12h",
      "replicates": 3
    },
    "outcome": "negative",
    "protocol": "Standard Western protocol with 12% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:2000, HRP-secondary 1:5000",
    "notes": "No significant change in cleaved Caspase-3 levels observed. Consider repeating with higher drug concentration. Loading control (GAPDH) unchanged.",
    "quality_score": 0.77,
    "num_lanes": 6,
    "experiment_date": "2025-03-25",
    "acquisition_date": "2025-03-26 05:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_017.png",
    "filename": "western_blot_017.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "IF-20250628-207",
    "experiment_type": "Western Blot",
    "cell_line": "A549",
    "target_protein": "pEGFR (Y1068)",
    "target_mw": "170 kDa",
    "target_function": "RTK signaling",
    "treatment": "Dasatinib",
    "treatment_target": "SRC/ABL",
    "concentration": "100nM",
    "conditions": {
      "drug": "Dasatinib",
      "concentration": "100nM",
      "time": "12h",
      "replicates": 3
    },
    "outcome": "positive",
    "protocol": "Standard Western protocol with 8% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:1000, HRP-secondary 1:5000",
    "notes": "Clear pEGFR (Y1068) band detected at expected MW (170 kDa). Dasatinib treatment shows dose-dependent effect. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.93,
    "num_lanes": 6,
    "experiment_date": "2025-07-13",
    "acquisition_date": "2025-07-15 00:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_018.png",
    "filename": "western_blot_018.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "IF-20251226-795",
    "experiment_type": "Western Blot",
    "cell_line": "U2OS",
    "target_protein": "cleaved Caspase-3",
    "target_mw": "17 kDa",
    "target_function": "Apoptosis",
    "treatment": "DMSO",
    "treatment_target": "Vehicle control",
    "concentration": "0.1%",
    "conditions": {
      "drug": "DMSO",
      "concentration": "0.1%",
      "time": "48h",
      "replicates": 4
    },
    "outcome": "positive",
    "protocol": "Standard Western protocol with 12% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:500, HRP-secondary 1:5000",
    "notes": "Clear cleaved Caspase-3 band detected at expected MW (17 kDa). DMSO treatment shows dose-dependent effect. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.71,
    "num_lanes": 6,
    "experiment_date": "2025-07-31",
    "acquisition_date": "2025-08-01 19:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_019.png",
    "filename": "western_blot_019.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "IF-20250219-966",
    "experiment_type": "Western Blot",
    "cell_line": "HCT116",
    "target_protein": "p21",
    "target_mw": "21 kDa",
    "target_function": "Cell cycle inhibitor",
    "treatment": "Nilotinib",
    "treatment_target": "BCR-ABL",
    "concentration": "500nM",
    "conditions": {
      "drug": "Nilotinib",
      "concentration": "500nM",
      "time": "12h",
      "replicates": 2
    },
    "outcome": "inconclusive",
    "protocol": "Standard Western protocol with 8% SDS-PAGE, transfer to PVDF, primary antibody 1:500, HRP-secondary 1:5000",
    "notes": "Results inconclusive. High background noise. Recommend optimizing blocking conditions. Loading control (GAPDH) unchanged.",
    "quality_score": 0.74,
    "num_lanes": 6,
    "experiment_date": "2025-03-19",
    "acquisition_date": "2025-03-20 10:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_020.png",
    "filename": "western_blot_020.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "WB-20250327-743",
    "experiment_type": "Western Blot",
    "cell_line": "K562",
    "target_protein": "cleaved PARP",
    "target_mw": "89 kDa",
    "target_function": "Apoptosis marker",
    "treatment": "Dasatinib",
    "treatment_target": "SRC/ABL",
    "concentration": "100nM",
    "conditions": {
      "drug": "Dasatinib",
      "concentration": "100nM",
      "time": "72h",
      "replicates": 4
    },
    "outcome": "dose_dependent",
    "protocol": "Standard Western protocol with 12% SDS-PAGE, transfer to PVDF, primary antibody 1:500, HRP-secondary 1:5000",
    "notes": "Dose-dependent inhibition of cleaved PARP. IC50 approximately 50nM. Loading control (GAPDH) unchanged.",
    "quality_score": 0.77,
    "num_lanes": 6,
    "experiment_date": "2026-01-09",
    "acquisition_date": "2026-01-10 05:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_021.png",
    "filename": "western_blot_021.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "WB-20250718-387",
    "experiment_type": "Western Blot",
    "cell_line": "A431",
    "target_protein": "BCL-2",
    "target_mw": "26 kDa",
    "target_function": "Anti-apoptotic",
    "treatment": "Lapatinib",
    "treatment_target": "HER2/EGFR",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Lapatinib",
      "concentration": "1\u03bcM",
      "time": "12h",
      "replicates": 3
    },
    "outcome": "negative",
    "protocol": "Standard Western protocol with 12% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:2000, HRP-secondary 1:5000",
    "notes": "No significant change in BCL-2 levels observed. Consider repeating with higher drug concentration. Loading control (\u03b2-actin) unchanged.",
    "quality_score": 0.79,
    "num_lanes": 6,
    "experiment_date": "2025-11-22",
    "acquisition_date": "2025-11-23 20:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_022.png",
    "filename": "western_blot_022.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "EXP-20250930-514",
    "experiment_type": "Western Blot",
    "cell_line": "U2OS",
    "target_protein": "pAKT (S473)",
    "target_mw": "60 kDa",
    "target_function": "PI3K signaling",
    "treatment": "Crizotinib",
    "treatment_target": "ALK/MET",
    "concentration": "250nM",
    "conditions": {
      "drug": "Crizotinib",
      "concentration": "250nM",
      "time": "24h",
      "replicates": 2
    },
    "outcome": "dose_dependent",
    "protocol": "Standard Western protocol with 12% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:500, HRP-secondary 1:5000",
    "notes": "Dose-dependent inhibition of pAKT (S473). IC50 approximately 10nM. Loading control (GAPDH) unchanged.",
    "quality_score": 0.72,
    "num_lanes": 6,
    "experiment_date": "2025-11-29",
    "acquisition_date": "2025-11-29 20:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_023.png",
    "filename": "western_blot_023.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "WB-20251012-031",
    "experiment_type": "Western Blot",
    "cell_line": "A431",
    "target_protein": "BCL-2",
    "target_mw": "26 kDa",
    "target_function": "Anti-apoptotic",
    "treatment": "Sorafenib",
    "treatment_target": "VEGFR/RAF",
    "concentration": "5\u03bcM",
    "conditions": {
      "drug": "Sorafenib",
      "concentration": "5\u03bcM",
      "time": "6h",
      "replicates": 4
    },
    "outcome": "positive",
    "protocol": "Standard Western protocol with 12% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:2000, HRP-secondary 1:5000",
    "notes": "Clear BCL-2 band detected at expected MW (26 kDa). Sorafenib treatment shows dose-dependent effect. Loading control (GAPDH) unchanged.",
    "quality_score": 0.95,
    "num_lanes": 6,
    "experiment_date": "2025-11-09",
    "acquisition_date": "2025-11-10 04:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_024.png",
    "filename": "western_blot_024.png"
  },
  {
    "image_type": "western_blot",
    "experiment_id": "WB-20250425-993",
    "experiment_type": "Western Blot",
    "cell_line": "THP-1",
    "target_protein": "Cyclin D1",
    "target_mw": "36 kDa",
    "target_function": "Cell cycle",
    "treatment": "Sorafenib",
    "treatment_target": "VEGFR/RAF",
    "concentration": "5\u03bcM",
    "conditions": {
      "drug": "Sorafenib",
      "concentration": "5\u03bcM",
      "time": "48h",
      "replicates": 4
    },
    "outcome": "positive",
    "protocol": "Standard Western protocol with 8% SDS-PAGE, transfer to nitrocellulose, primary antibody 1:2000, HRP-secondary 1:5000",
    "notes": "Clear Cyclin D1 band detected at expected MW (36 kDa). Sorafenib treatment shows dose-dependent effect. Loading control (GAPDH) unchanged.",
    "quality_score": 0.94,
    "num_lanes": 6,
    "experiment_date": "2025-09-24",
    "acquisition_date": "2025-09-25 22:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\western_blot_025.png",
    "filename": "western_blot_025.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "EXP-20251111-179",
    "experiment_type": "SDS-PAGE (Sypro)",
    "gel_percentage": "10%",
    "stain": "Sypro",
    "protein": "cleaved PARP",
    "expression_system": "CHO",
    "purpose": "Expression analysis",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "100V"
    },
    "outcome": "dose_dependent",
    "notes": "Expression analysis of cleaved PARP. Multiple bands suggest partial degradation.",
    "quality_score": 0.81,
    "num_lanes": 8,
    "experiment_date": "2025-09-24",
    "acquisition_date": "2025-09-26 01:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_001.png",
    "filename": "gel_electrophoresis_001.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "FC-20250323-423",
    "experiment_type": "SDS-PAGE (Sypro)",
    "gel_percentage": "8%",
    "stain": "Sypro",
    "protein": "pEGFR (Y1068)",
    "expression_system": "Sf9 insect cells",
    "purpose": "Co-IP",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "150V"
    },
    "outcome": "negative",
    "notes": "Co-IP of pEGFR (Y1068). Multiple bands suggest partial degradation.",
    "quality_score": 0.9,
    "num_lanes": 8,
    "experiment_date": "2025-12-01",
    "acquisition_date": "2025-12-02 14:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_002.png",
    "filename": "gel_electrophoresis_002.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "FC-20250908-998",
    "experiment_type": "SDS-PAGE (Ethidium Bromide)",
    "gel_percentage": "8%",
    "stain": "Ethidium Bromide",
    "protein": "p53",
    "expression_system": "HEK293",
    "purpose": "Co-IP",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "150V"
    },
    "outcome": "positive",
    "notes": "Co-IP of p53. Expected MW confirmed.",
    "quality_score": 0.71,
    "num_lanes": 8,
    "experiment_date": "2026-01-13",
    "acquisition_date": "2026-01-15 18:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_003.png",
    "filename": "gel_electrophoresis_003.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "EXP-20250911-007",
    "experiment_type": "SDS-PAGE (Sypro)",
    "gel_percentage": "8%",
    "stain": "Sypro",
    "protein": "BCL-2",
    "expression_system": "E. coli BL21",
    "purpose": "Protein purification",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "150V"
    },
    "outcome": "positive",
    "notes": "Protein purification of BCL-2. High purity achieved.",
    "quality_score": 0.7,
    "num_lanes": 8,
    "experiment_date": "2025-10-28",
    "acquisition_date": "2025-10-30 11:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_004.png",
    "filename": "gel_electrophoresis_004.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "IF-20250709-336",
    "experiment_type": "SDS-PAGE (Sypro)",
    "gel_percentage": "10%",
    "stain": "Sypro",
    "protein": "BAX",
    "expression_system": "Sf9 insect cells",
    "purpose": "Pull-down assay",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "100V"
    },
    "outcome": "dose_dependent",
    "notes": "Pull-down assay of BAX. Multiple bands suggest partial degradation.",
    "quality_score": 0.69,
    "num_lanes": 8,
    "experiment_date": "2025-12-26",
    "acquisition_date": "2025-12-28 01:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_005.png",
    "filename": "gel_electrophoresis_005.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "WB-20250603-172",
    "experiment_type": "SDS-PAGE (Coomassie)",
    "gel_percentage": "8%",
    "stain": "Coomassie",
    "protein": "p21",
    "expression_system": "E. coli BL21",
    "purpose": "Co-IP",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "100V"
    },
    "outcome": "positive",
    "notes": "Co-IP of p21. Expected MW confirmed.",
    "quality_score": 0.85,
    "num_lanes": 8,
    "experiment_date": "2025-12-11",
    "acquisition_date": "2025-12-12 14:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_006.png",
    "filename": "gel_electrophoresis_006.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "FC-20250702-898",
    "experiment_type": "SDS-PAGE (Coomassie)",
    "gel_percentage": "15%",
    "stain": "Coomassie",
    "protein": "p21",
    "expression_system": "Sf9 insect cells",
    "purpose": "Protein purification",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "150V"
    },
    "outcome": "negative",
    "notes": "Protein purification of p21. High purity achieved.",
    "quality_score": 0.72,
    "num_lanes": 8,
    "experiment_date": "2025-09-04",
    "acquisition_date": "2025-09-06 05:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_007.png",
    "filename": "gel_electrophoresis_007.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "WB-20250210-758",
    "experiment_type": "SDS-PAGE (Ethidium Bromide)",
    "gel_percentage": "8%",
    "stain": "Ethidium Bromide",
    "protein": "total AKT",
    "expression_system": "E. coli BL21",
    "purpose": "Protein purification",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "120V"
    },
    "outcome": "dose_dependent",
    "notes": "Protein purification of total AKT. Expected MW confirmed.",
    "quality_score": 0.82,
    "num_lanes": 8,
    "experiment_date": "2025-04-15",
    "acquisition_date": "2025-04-15 21:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_008.png",
    "filename": "gel_electrophoresis_008.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "WB-20250507-362",
    "experiment_type": "SDS-PAGE (Ethidium Bromide)",
    "gel_percentage": "10%",
    "stain": "Ethidium Bromide",
    "protein": "cleaved PARP",
    "expression_system": "HEK293",
    "purpose": "Co-IP",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "120V"
    },
    "outcome": "positive",
    "notes": "Co-IP of cleaved PARP. Multiple bands suggest partial degradation.",
    "quality_score": 0.78,
    "num_lanes": 8,
    "experiment_date": "2025-06-12",
    "acquisition_date": "2025-06-13 22:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_009.png",
    "filename": "gel_electrophoresis_009.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "GEL-20250216-599",
    "experiment_type": "SDS-PAGE (Sypro)",
    "gel_percentage": "8%",
    "stain": "Sypro",
    "protein": "\u03b2-actin",
    "expression_system": "HEK293",
    "purpose": "Co-IP",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "150V"
    },
    "outcome": "inconclusive",
    "notes": "Co-IP of \u03b2-actin. Multiple bands suggest partial degradation.",
    "quality_score": 0.83,
    "num_lanes": 8,
    "experiment_date": "2025-02-04",
    "acquisition_date": "2025-02-06 16:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_010.png",
    "filename": "gel_electrophoresis_010.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "EXP-20250407-338",
    "experiment_type": "SDS-PAGE (Ethidium Bromide)",
    "gel_percentage": "8%",
    "stain": "Ethidium Bromide",
    "protein": "pERK1/2 (T202/Y204)",
    "expression_system": "HEK293",
    "purpose": "Expression analysis",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "100V"
    },
    "outcome": "inconclusive",
    "notes": "Expression analysis of pERK1/2 (T202/Y204). Multiple bands suggest partial degradation.",
    "quality_score": 0.94,
    "num_lanes": 8,
    "experiment_date": "2025-11-01",
    "acquisition_date": "2025-11-02 18:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_011.png",
    "filename": "gel_electrophoresis_011.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "IF-20250617-092",
    "experiment_type": "SDS-PAGE (Coomassie)",
    "gel_percentage": "15%",
    "stain": "Coomassie",
    "protein": "\u03b2-actin",
    "expression_system": "CHO",
    "purpose": "Pull-down assay",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "120V"
    },
    "outcome": "positive",
    "notes": "Pull-down assay of \u03b2-actin. Yield approximately 2mg/L.",
    "quality_score": 0.67,
    "num_lanes": 8,
    "experiment_date": "2025-03-31",
    "acquisition_date": "2025-04-01 18:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_012.png",
    "filename": "gel_electrophoresis_012.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "GEL-20250920-823",
    "experiment_type": "SDS-PAGE (Ethidium Bromide)",
    "gel_percentage": "12%",
    "stain": "Ethidium Bromide",
    "protein": "total AKT",
    "expression_system": "HEK293",
    "purpose": "Protein purification",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "100V"
    },
    "outcome": "inconclusive",
    "notes": "Protein purification of total AKT. Yield approximately 2mg/L.",
    "quality_score": 0.66,
    "num_lanes": 8,
    "experiment_date": "2025-03-11",
    "acquisition_date": "2025-03-13 15:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_013.png",
    "filename": "gel_electrophoresis_013.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "WB-20250715-168",
    "experiment_type": "SDS-PAGE (Sypro)",
    "gel_percentage": "15%",
    "stain": "Sypro",
    "protein": "\u03b2-actin",
    "expression_system": "HEK293",
    "purpose": "Protein purification",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "100V"
    },
    "outcome": "inconclusive",
    "notes": "Protein purification of \u03b2-actin. High purity achieved.",
    "quality_score": 0.69,
    "num_lanes": 8,
    "experiment_date": "2026-01-01",
    "acquisition_date": "2026-01-03 16:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_014.png",
    "filename": "gel_electrophoresis_014.png"
  },
  {
    "image_type": "gel",
    "experiment_id": "WB-20250612-395",
    "experiment_type": "SDS-PAGE (Sypro)",
    "gel_percentage": "12%",
    "stain": "Sypro",
    "protein": "BAX",
    "expression_system": "HEK293",
    "purpose": "Pull-down assay",
    "conditions": {
      "gel_type": "SDS-PAGE",
      "running_buffer": "Tris-Glycine",
      "voltage": "100V"
    },
    "outcome": "positive",
    "notes": "Pull-down assay of BAX. Multiple bands suggest partial degradation.",
    "quality_score": 0.75,
    "num_lanes": 8,
    "experiment_date": "2025-09-29",
    "acquisition_date": "2025-09-30 01:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\gel_electrophoresis_015.png",
    "filename": "gel_electrophoresis_015.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "FC-20250425-164",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "DAPI",
    "staining_purpose": "Nuclear stain",
    "channels": [
      "blue"
    ],
    "cell_line": "HeLa",
    "treatment": "Vemurafenib",
    "treatment_target": "BRAF V600E",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Vemurafenib",
      "concentration": "1\u03bcM",
      "time": "48h"
    },
    "magnification": "40x",
    "objective": "EC Plan-Neofluar",
    "microscope": "Nikon A1R",
    "outcome": "negative",
    "notes": "Nuclear stain imaging in 25 cells. Treatment: Vemurafenib 1\u03bcM.",
    "quality_score": 0.72,
    "cell_count": 25,
    "experiment_date": "2025-10-22",
    "acquisition_date": "2025-10-23 21:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_001.png",
    "filename": "fluorescence_001.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "WB-20260104-986",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "CellMask Orange",
    "staining_purpose": "Plasma membrane",
    "channels": [
      "orange"
    ],
    "cell_line": "RAW264.7",
    "treatment": "Trametinib",
    "treatment_target": "MEK1/2",
    "concentration": "100nM",
    "conditions": {
      "drug": "Trametinib",
      "concentration": "100nM",
      "time": "12h"
    },
    "magnification": "10x",
    "objective": "EC Plan-Neofluar",
    "microscope": "Zeiss LSM 880",
    "outcome": "inconclusive",
    "notes": "Plasma membrane imaging in 18 cells. Treatment: Trametinib 100nM.",
    "quality_score": 0.84,
    "cell_count": 18,
    "experiment_date": "2025-12-18",
    "acquisition_date": "2025-12-19 19:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_002.png",
    "filename": "fluorescence_002.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "EXP-20250423-700",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "LysoTracker Green",
    "staining_purpose": "Lysosomes",
    "channels": [
      "green"
    ],
    "cell_line": "THP-1",
    "treatment": "Trametinib",
    "treatment_target": "MEK1/2",
    "concentration": "100nM",
    "conditions": {
      "drug": "Trametinib",
      "concentration": "100nM",
      "time": "24h"
    },
    "magnification": "63x",
    "objective": "LD Plan-Neofluar",
    "microscope": "Olympus FV3000",
    "outcome": "negative",
    "notes": "Lysosomes imaging in 24 cells. Treatment: Trametinib 100nM.",
    "quality_score": 0.89,
    "cell_count": 24,
    "experiment_date": "2025-11-20",
    "acquisition_date": "2025-11-21 08:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_003.png",
    "filename": "fluorescence_003.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "EXP-20251008-782",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "CellMask Orange",
    "staining_purpose": "Plasma membrane",
    "channels": [
      "orange"
    ],
    "cell_line": "K562",
    "treatment": "DMSO",
    "treatment_target": "Vehicle control",
    "concentration": "0.1%",
    "conditions": {
      "drug": "DMSO",
      "concentration": "0.1%",
      "time": "24h"
    },
    "magnification": "10x",
    "objective": "LD Plan-Neofluar",
    "microscope": "Nikon A1R",
    "outcome": "positive",
    "notes": "Plasma membrane imaging in 23 cells. Treatment: DMSO 0.1%.",
    "quality_score": 0.76,
    "cell_count": 23,
    "experiment_date": "2025-10-22",
    "acquisition_date": "2025-10-24 16:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_004.png",
    "filename": "fluorescence_004.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "WB-20250910-065",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "Annexin V-FITC / PI",
    "staining_purpose": "Apoptosis detection",
    "channels": [
      "green",
      "red"
    ],
    "cell_line": "MDA-MB-231",
    "treatment": "Gefitinib",
    "treatment_target": "EGFR",
    "concentration": "100nM",
    "conditions": {
      "drug": "Gefitinib",
      "concentration": "100nM",
      "time": "24h"
    },
    "magnification": "40x",
    "objective": "EC Plan-Neofluar",
    "microscope": "Nikon A1R",
    "outcome": "positive",
    "notes": "~63% apoptotic cells at 48h. Green = early apoptosis (Annexin V+/PI-), Red = late apoptosis. Treatment: Gefitinib 100nM.",
    "quality_score": 0.9,
    "cell_count": 25,
    "experiment_date": "2025-12-14",
    "acquisition_date": "2025-12-16 05:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_005.png",
    "filename": "fluorescence_005.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "GEL-20250302-941",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "CellMask Orange",
    "staining_purpose": "Plasma membrane",
    "channels": [
      "orange"
    ],
    "cell_line": "HEK293",
    "treatment": "Trametinib",
    "treatment_target": "MEK1/2",
    "concentration": "100nM",
    "conditions": {
      "drug": "Trametinib",
      "concentration": "100nM",
      "time": "72h"
    },
    "magnification": "20x",
    "objective": "Plan-Apochromat",
    "microscope": "Nikon A1R",
    "outcome": "dose_dependent",
    "notes": "Plasma membrane imaging in 8 cells. Treatment: Trametinib 100nM.",
    "quality_score": 0.74,
    "cell_count": 8,
    "experiment_date": "2025-08-27",
    "acquisition_date": "2025-08-28 11:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_006.png",
    "filename": "fluorescence_006.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "FC-20250821-468",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "Annexin V-FITC / PI",
    "staining_purpose": "Apoptosis detection",
    "channels": [
      "green",
      "red"
    ],
    "cell_line": "U2OS",
    "treatment": "Lapatinib",
    "treatment_target": "HER2/EGFR",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Lapatinib",
      "concentration": "1\u03bcM",
      "time": "6h"
    },
    "magnification": "10x",
    "objective": "Plan-Apochromat",
    "microscope": "Nikon A1R",
    "outcome": "negative",
    "notes": "Minimal apoptosis (<10%). No significant drug effect observed. Treatment: Lapatinib 1\u03bcM.",
    "quality_score": 0.92,
    "cell_count": 15,
    "experiment_date": "2025-03-20",
    "acquisition_date": "2025-03-21 02:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_007.png",
    "filename": "fluorescence_007.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "GEL-20251217-741",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "Hoechst 33342",
    "staining_purpose": "DNA stain",
    "channels": [
      "blue"
    ],
    "cell_line": "A431",
    "treatment": "Crizotinib",
    "treatment_target": "ALK/MET",
    "concentration": "250nM",
    "conditions": {
      "drug": "Crizotinib",
      "concentration": "250nM",
      "time": "12h"
    },
    "magnification": "20x",
    "objective": "EC Plan-Neofluar",
    "microscope": "Olympus FV3000",
    "outcome": "negative",
    "notes": "DNA stain imaging in 14 cells. Treatment: Crizotinib 250nM.",
    "quality_score": 0.93,
    "cell_count": 14,
    "experiment_date": "2025-06-15",
    "acquisition_date": "2025-06-16 07:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_008.png",
    "filename": "fluorescence_008.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "WB-20250630-878",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "DAPI",
    "staining_purpose": "Nuclear stain",
    "channels": [
      "blue"
    ],
    "cell_line": "H1975",
    "treatment": "Nilotinib",
    "treatment_target": "BCR-ABL",
    "concentration": "500nM",
    "conditions": {
      "drug": "Nilotinib",
      "concentration": "500nM",
      "time": "24h"
    },
    "magnification": "20x",
    "objective": "EC Plan-Neofluar",
    "microscope": "Zeiss LSM 880",
    "outcome": "inconclusive",
    "notes": "Nuclear stain imaging in 9 cells. Treatment: Nilotinib 500nM.",
    "quality_score": 0.89,
    "cell_count": 9,
    "experiment_date": "2025-03-08",
    "acquisition_date": "2025-03-08 19:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_009.png",
    "filename": "fluorescence_009.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "IF-20250922-764",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "Annexin V-FITC / PI",
    "staining_purpose": "Apoptosis detection",
    "channels": [
      "green",
      "red"
    ],
    "cell_line": "PC3",
    "treatment": "Sorafenib",
    "treatment_target": "VEGFR/RAF",
    "concentration": "5\u03bcM",
    "conditions": {
      "drug": "Sorafenib",
      "concentration": "5\u03bcM",
      "time": "48h"
    },
    "magnification": "40x",
    "objective": "Plan-Apochromat",
    "microscope": "Olympus FV3000",
    "outcome": "positive",
    "notes": "~46% apoptotic cells at 48h. Green = early apoptosis (Annexin V+/PI-), Red = late apoptosis. Treatment: Sorafenib 5\u03bcM.",
    "quality_score": 0.87,
    "cell_count": 16,
    "experiment_date": "2025-08-23",
    "acquisition_date": "2025-08-24 05:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_010.png",
    "filename": "fluorescence_010.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "GEL-20250327-779",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "DAPI",
    "staining_purpose": "Nuclear stain",
    "channels": [
      "blue"
    ],
    "cell_line": "RAW264.7",
    "treatment": "Sorafenib",
    "treatment_target": "VEGFR/RAF",
    "concentration": "5\u03bcM",
    "conditions": {
      "drug": "Sorafenib",
      "concentration": "5\u03bcM",
      "time": "48h"
    },
    "magnification": "20x",
    "objective": "EC Plan-Neofluar",
    "microscope": "Zeiss LSM 880",
    "outcome": "inconclusive",
    "notes": "Nuclear stain imaging in 13 cells. Treatment: Sorafenib 5\u03bcM.",
    "quality_score": 0.9,
    "cell_count": 13,
    "experiment_date": "2025-04-26",
    "acquisition_date": "2025-04-28 01:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_011.png",
    "filename": "fluorescence_011.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "IF-20250325-060",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "ER-Tracker Blue",
    "staining_purpose": "Endoplasmic reticulum",
    "channels": [
      "blue"
    ],
    "cell_line": "MDA-MB-231",
    "treatment": "Erlotinib",
    "treatment_target": "EGFR",
    "concentration": "500nM",
    "conditions": {
      "drug": "Erlotinib",
      "concentration": "500nM",
      "time": "48h"
    },
    "magnification": "63x",
    "objective": "LD Plan-Neofluar",
    "microscope": "Zeiss LSM 880",
    "outcome": "positive",
    "notes": "Endoplasmic reticulum imaging in 25 cells. Treatment: Erlotinib 500nM.",
    "quality_score": 0.72,
    "cell_count": 25,
    "experiment_date": "2025-10-04",
    "acquisition_date": "2025-10-06 18:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_012.png",
    "filename": "fluorescence_012.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "EXP-20250604-913",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "DAPI",
    "staining_purpose": "Nuclear stain",
    "channels": [
      "blue"
    ],
    "cell_line": "HEK293",
    "treatment": "Crizotinib",
    "treatment_target": "ALK/MET",
    "concentration": "250nM",
    "conditions": {
      "drug": "Crizotinib",
      "concentration": "250nM",
      "time": "24h"
    },
    "magnification": "10x",
    "objective": "EC Plan-Neofluar",
    "microscope": "Leica SP8",
    "outcome": "positive",
    "notes": "Nuclear stain imaging in 22 cells. Treatment: Crizotinib 250nM.",
    "quality_score": 0.97,
    "cell_count": 22,
    "experiment_date": "2025-08-18",
    "acquisition_date": "2025-08-19 06:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_013.png",
    "filename": "fluorescence_013.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "IF-20251002-449",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "Annexin V-FITC / PI",
    "staining_purpose": "Apoptosis detection",
    "channels": [
      "green",
      "red"
    ],
    "cell_line": "HEK293",
    "treatment": "Nilotinib",
    "treatment_target": "BCR-ABL",
    "concentration": "500nM",
    "conditions": {
      "drug": "Nilotinib",
      "concentration": "500nM",
      "time": "72h"
    },
    "magnification": "40x",
    "objective": "Plan-Apochromat",
    "microscope": "Zeiss LSM 880",
    "outcome": "negative",
    "notes": "Minimal apoptosis (<10%). No significant drug effect observed. Treatment: Nilotinib 500nM.",
    "quality_score": 0.71,
    "cell_count": 15,
    "experiment_date": "2025-09-29",
    "acquisition_date": "2025-09-30 12:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_014.png",
    "filename": "fluorescence_014.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "IF-20250906-085",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "MitoTracker Red",
    "staining_purpose": "Mitochondria",
    "channels": [
      "red"
    ],
    "cell_line": "MDA-MB-231",
    "treatment": "Sorafenib",
    "treatment_target": "VEGFR/RAF",
    "concentration": "5\u03bcM",
    "conditions": {
      "drug": "Sorafenib",
      "concentration": "5\u03bcM",
      "time": "6h"
    },
    "magnification": "10x",
    "objective": "LD Plan-Neofluar",
    "microscope": "Nikon A1R",
    "outcome": "positive",
    "notes": "Mitochondrial network visualized in 17 cells. Drug treatment causes mitochondrial fragmentation. Treatment: Sorafenib 5\u03bcM.",
    "quality_score": 0.74,
    "cell_count": 17,
    "experiment_date": "2026-01-17",
    "acquisition_date": "2026-01-19 01:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_015.png",
    "filename": "fluorescence_015.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "GEL-20250510-025",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "MitoTracker Red",
    "staining_purpose": "Mitochondria",
    "channels": [
      "red"
    ],
    "cell_line": "MDA-MB-231",
    "treatment": "Lapatinib",
    "treatment_target": "HER2/EGFR",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Lapatinib",
      "concentration": "1\u03bcM",
      "time": "12h"
    },
    "magnification": "40x",
    "objective": "EC Plan-Neofluar",
    "microscope": "Olympus FV3000",
    "outcome": "positive",
    "notes": "Mitochondrial network visualized in 22 cells. Drug treatment causes mitochondrial fragmentation. Treatment: Lapatinib 1\u03bcM.",
    "quality_score": 0.81,
    "cell_count": 22,
    "experiment_date": "2025-05-18",
    "acquisition_date": "2025-05-19 06:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_016.png",
    "filename": "fluorescence_016.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "IF-20251027-789",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "Phalloidin-FITC",
    "staining_purpose": "Actin cytoskeleton",
    "channels": [
      "green"
    ],
    "cell_line": "H1975",
    "treatment": "Lapatinib",
    "treatment_target": "HER2/EGFR",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Lapatinib",
      "concentration": "1\u03bcM",
      "time": "12h"
    },
    "magnification": "40x",
    "objective": "LD Plan-Neofluar",
    "microscope": "Leica SP8",
    "outcome": "dose_dependent",
    "notes": "Actin cytoskeleton imaging in 21 cells. Treatment: Lapatinib 1\u03bcM.",
    "quality_score": 0.94,
    "cell_count": 21,
    "experiment_date": "2025-05-06",
    "acquisition_date": "2025-05-07 02:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_017.png",
    "filename": "fluorescence_017.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "IF-20251107-231",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "LysoTracker Green",
    "staining_purpose": "Lysosomes",
    "channels": [
      "green"
    ],
    "cell_line": "HeLa",
    "treatment": "Dasatinib",
    "treatment_target": "SRC/ABL",
    "concentration": "100nM",
    "conditions": {
      "drug": "Dasatinib",
      "concentration": "100nM",
      "time": "48h"
    },
    "magnification": "40x",
    "objective": "LD Plan-Neofluar",
    "microscope": "Olympus FV3000",
    "outcome": "negative",
    "notes": "Lysosomes imaging in 24 cells. Treatment: Dasatinib 100nM.",
    "quality_score": 0.97,
    "cell_count": 24,
    "experiment_date": "2025-03-25",
    "acquisition_date": "2025-03-27 05:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_018.png",
    "filename": "fluorescence_018.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "FC-20250508-545",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "Annexin V-FITC / PI",
    "staining_purpose": "Apoptosis detection",
    "channels": [
      "green",
      "red"
    ],
    "cell_line": "PC3",
    "treatment": "Staurosporine",
    "treatment_target": "Pan-kinase",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Staurosporine",
      "concentration": "1\u03bcM",
      "time": "6h"
    },
    "magnification": "20x",
    "objective": "Plan-Apochromat",
    "microscope": "Leica SP8",
    "outcome": "dose_dependent",
    "notes": "Variable results. Some cells show early apoptotic markers. Treatment: Staurosporine 1\u03bcM.",
    "quality_score": 0.71,
    "cell_count": 16,
    "experiment_date": "2025-07-31",
    "acquisition_date": "2025-08-01 03:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_019.png",
    "filename": "fluorescence_019.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "EXP-20251224-275",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "Annexin V-FITC / PI",
    "staining_purpose": "Apoptosis detection",
    "channels": [
      "green",
      "red"
    ],
    "cell_line": "MDA-MB-231",
    "treatment": "Trametinib",
    "treatment_target": "MEK1/2",
    "concentration": "100nM",
    "conditions": {
      "drug": "Trametinib",
      "concentration": "100nM",
      "time": "48h"
    },
    "magnification": "40x",
    "objective": "Plan-Apochromat",
    "microscope": "Nikon A1R",
    "outcome": "dose_dependent",
    "notes": "Variable results. Some cells show early apoptotic markers. Treatment: Trametinib 100nM.",
    "quality_score": 0.87,
    "cell_count": 14,
    "experiment_date": "2025-02-05",
    "acquisition_date": "2025-02-07 09:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_020.png",
    "filename": "fluorescence_020.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "GEL-20251022-625",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "LysoTracker Green",
    "staining_purpose": "Lysosomes",
    "channels": [
      "green"
    ],
    "cell_line": "THP-1",
    "treatment": "Rapamycin",
    "treatment_target": "mTOR",
    "concentration": "100nM",
    "conditions": {
      "drug": "Rapamycin",
      "concentration": "100nM",
      "time": "72h"
    },
    "magnification": "40x",
    "objective": "Plan-Apochromat",
    "microscope": "Zeiss LSM 880",
    "outcome": "inconclusive",
    "notes": "Lysosomes imaging in 20 cells. Treatment: Rapamycin 100nM.",
    "quality_score": 0.79,
    "cell_count": 20,
    "experiment_date": "2025-09-02",
    "acquisition_date": "2025-09-03 01:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_021.png",
    "filename": "fluorescence_021.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "IF-20250407-950",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "DAPI",
    "staining_purpose": "Nuclear stain",
    "channels": [
      "blue"
    ],
    "cell_line": "HEK293",
    "treatment": "Staurosporine",
    "treatment_target": "Pan-kinase",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Staurosporine",
      "concentration": "1\u03bcM",
      "time": "6h"
    },
    "magnification": "20x",
    "objective": "EC Plan-Neofluar",
    "microscope": "Nikon A1R",
    "outcome": "positive",
    "notes": "Nuclear stain imaging in 14 cells. Treatment: Staurosporine 1\u03bcM.",
    "quality_score": 0.77,
    "cell_count": 14,
    "experiment_date": "2025-12-26",
    "acquisition_date": "2025-12-27 17:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_022.png",
    "filename": "fluorescence_022.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "GEL-20251201-931",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "CellMask Orange",
    "staining_purpose": "Plasma membrane",
    "channels": [
      "orange"
    ],
    "cell_line": "HCC827",
    "treatment": "Gefitinib",
    "treatment_target": "EGFR",
    "concentration": "100nM",
    "conditions": {
      "drug": "Gefitinib",
      "concentration": "100nM",
      "time": "48h"
    },
    "magnification": "63x",
    "objective": "Plan-Apochromat",
    "microscope": "Olympus FV3000",
    "outcome": "dose_dependent",
    "notes": "Plasma membrane imaging in 17 cells. Treatment: Gefitinib 100nM.",
    "quality_score": 0.91,
    "cell_count": 17,
    "experiment_date": "2025-10-05",
    "acquisition_date": "2025-10-05 20:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_023.png",
    "filename": "fluorescence_023.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "FC-20250426-050",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "ER-Tracker Blue",
    "staining_purpose": "Endoplasmic reticulum",
    "channels": [
      "blue"
    ],
    "cell_line": "MCF7",
    "treatment": "Erlotinib",
    "treatment_target": "EGFR",
    "concentration": "500nM",
    "conditions": {
      "drug": "Erlotinib",
      "concentration": "500nM",
      "time": "72h"
    },
    "magnification": "63x",
    "objective": "LD Plan-Neofluar",
    "microscope": "Zeiss LSM 880",
    "outcome": "inconclusive",
    "notes": "Endoplasmic reticulum imaging in 18 cells. Treatment: Erlotinib 500nM.",
    "quality_score": 0.8,
    "cell_count": 18,
    "experiment_date": "2025-10-27",
    "acquisition_date": "2025-10-28 03:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_024.png",
    "filename": "fluorescence_024.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "EXP-20251207-399",
    "experiment_type": "Fluorescence Microscopy",
    "staining": "CellMask Orange",
    "staining_purpose": "Plasma membrane",
    "channels": [
      "orange"
    ],
    "cell_line": "MDA-MB-231",
    "treatment": "Gefitinib",
    "treatment_target": "EGFR",
    "concentration": "100nM",
    "conditions": {
      "drug": "Gefitinib",
      "concentration": "100nM",
      "time": "12h"
    },
    "magnification": "40x",
    "objective": "EC Plan-Neofluar",
    "microscope": "Zeiss LSM 880",
    "outcome": "dose_dependent",
    "notes": "Plasma membrane imaging in 15 cells. Treatment: Gefitinib 100nM.",
    "quality_score": 0.77,
    "cell_count": 15,
    "experiment_date": "2025-10-22",
    "acquisition_date": "2025-10-23 13:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\fluorescence_025.png",
    "filename": "fluorescence_025.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "WB-20251015-440",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "DIC",
    "cell_line": "A431",
    "treatment": "Staurosporine",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Staurosporine",
      "concentration": "1\u03bcM",
      "time": "48h"
    },
    "magnification": "10x",
    "outcome": "positive",
    "notes": "Cell morphology assessment. 36 cells visible. Cells appear healthy with normal morphology.",
    "quality_score": 0.74,
    "cell_count": 36,
    "experiment_date": "2025-03-24",
    "acquisition_date": "2025-03-26 14:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_001.png",
    "filename": "brightfield_001.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "WB-20250708-701",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "Phase Contrast",
    "cell_line": "U2OS",
    "treatment": "Rapamycin",
    "concentration": "100nM",
    "conditions": {
      "drug": "Rapamycin",
      "concentration": "100nM",
      "time": "72h"
    },
    "magnification": "40x",
    "outcome": "inconclusive",
    "notes": "Cell morphology assessment. 19 cells visible. Some cells show rounded morphology suggesting stress.",
    "quality_score": 0.93,
    "cell_count": 19,
    "experiment_date": "2026-01-28",
    "acquisition_date": "2026-01-29 01:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_002.png",
    "filename": "brightfield_002.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "FC-20250922-054",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "Phase Contrast",
    "cell_line": "MDA-MB-231",
    "treatment": "Trametinib",
    "concentration": "100nM",
    "conditions": {
      "drug": "Trametinib",
      "concentration": "100nM",
      "time": "24h"
    },
    "magnification": "10x",
    "outcome": "dose_dependent",
    "notes": "Cell morphology assessment. 38 cells visible. Increased cell density observed.",
    "quality_score": 0.79,
    "cell_count": 38,
    "experiment_date": "2025-11-11",
    "acquisition_date": "2025-11-13 10:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_003.png",
    "filename": "brightfield_003.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "EXP-20251201-084",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "DIC",
    "cell_line": "K562",
    "treatment": "Dasatinib",
    "concentration": "100nM",
    "conditions": {
      "drug": "Dasatinib",
      "concentration": "100nM",
      "time": "48h"
    },
    "magnification": "40x",
    "outcome": "dose_dependent",
    "notes": "Cell morphology assessment. 27 cells visible. Drug-treated cells show elongated morphology.",
    "quality_score": 0.71,
    "cell_count": 27,
    "experiment_date": "2025-10-08",
    "acquisition_date": "2025-10-10 09:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_004.png",
    "filename": "brightfield_004.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "WB-20250608-009",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "Brightfield",
    "cell_line": "H1975",
    "treatment": "Trametinib",
    "concentration": "100nM",
    "conditions": {
      "drug": "Trametinib",
      "concentration": "100nM",
      "time": "72h"
    },
    "magnification": "20x",
    "outcome": "positive",
    "notes": "Cell morphology assessment. 21 cells visible. Drug-treated cells show elongated morphology.",
    "quality_score": 0.94,
    "cell_count": 21,
    "experiment_date": "2025-02-24",
    "acquisition_date": "2025-02-25 23:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_005.png",
    "filename": "brightfield_005.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "EXP-20251004-086",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "DIC",
    "cell_line": "HCC827",
    "treatment": "Lapatinib",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Lapatinib",
      "concentration": "1\u03bcM",
      "time": "72h"
    },
    "magnification": "20x",
    "outcome": "dose_dependent",
    "notes": "Cell morphology assessment. 30 cells visible. Increased cell density observed.",
    "quality_score": 0.7,
    "cell_count": 30,
    "experiment_date": "2025-04-18",
    "acquisition_date": "2025-04-19 12:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_006.png",
    "filename": "brightfield_006.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "GEL-20260117-641",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "Brightfield",
    "cell_line": "SW480",
    "treatment": "Nilotinib",
    "concentration": "500nM",
    "conditions": {
      "drug": "Nilotinib",
      "concentration": "500nM",
      "time": "6h"
    },
    "magnification": "10x",
    "outcome": "inconclusive",
    "notes": "Cell morphology assessment. 23 cells visible. Some cells show rounded morphology suggesting stress.",
    "quality_score": 0.91,
    "cell_count": 23,
    "experiment_date": "2025-09-29",
    "acquisition_date": "2025-09-30 08:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_007.png",
    "filename": "brightfield_007.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "WB-20250812-576",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "Brightfield",
    "cell_line": "MCF7",
    "treatment": "Imatinib",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Imatinib",
      "concentration": "1\u03bcM",
      "time": "48h"
    },
    "magnification": "40x",
    "outcome": "inconclusive",
    "notes": "Cell morphology assessment. 23 cells visible. Cells appear healthy with normal morphology.",
    "quality_score": 0.86,
    "cell_count": 23,
    "experiment_date": "2025-11-17",
    "acquisition_date": "2025-11-19 05:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_008.png",
    "filename": "brightfield_008.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "GEL-20251107-742",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "Brightfield",
    "cell_line": "HEK293",
    "treatment": "Staurosporine",
    "concentration": "1\u03bcM",
    "conditions": {
      "drug": "Staurosporine",
      "concentration": "1\u03bcM",
      "time": "12h"
    },
    "magnification": "10x",
    "outcome": "negative",
    "notes": "Cell morphology assessment. 26 cells visible. Drug-treated cells show elongated morphology.",
    "quality_score": 0.9,
    "cell_count": 26,
    "experiment_date": "2025-06-21",
    "acquisition_date": "2025-06-21 20:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_009.png",
    "filename": "brightfield_009.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "EXP-20250228-464",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "Phase Contrast",
    "cell_line": "HCC827",
    "treatment": "Sorafenib",
    "concentration": "5\u03bcM",
    "conditions": {
      "drug": "Sorafenib",
      "concentration": "5\u03bcM",
      "time": "12h"
    },
    "magnification": "10x",
    "outcome": "dose_dependent",
    "notes": "Cell morphology assessment. 36 cells visible. Some cells show rounded morphology suggesting stress.",
    "quality_score": 0.76,
    "cell_count": 36,
    "experiment_date": "2025-02-23",
    "acquisition_date": "2025-02-25 12:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_010.png",
    "filename": "brightfield_010.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "EXP-20250428-012",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "Phase Contrast",
    "cell_line": "THP-1",
    "treatment": "Trametinib",
    "concentration": "100nM",
    "conditions": {
      "drug": "Trametinib",
      "concentration": "100nM",
      "time": "72h"
    },
    "magnification": "20x",
    "outcome": "dose_dependent",
    "notes": "Cell morphology assessment. 18 cells visible. Cells appear healthy with normal morphology.",
    "quality_score": 0.84,
    "cell_count": 18,
    "experiment_date": "2025-03-18",
    "acquisition_date": "2025-03-20 15:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_011.png",
    "filename": "brightfield_011.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "GEL-20250614-665",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "DIC",
    "cell_line": "RAW264.7",
    "treatment": "Erlotinib",
    "concentration": "500nM",
    "conditions": {
      "drug": "Erlotinib",
      "concentration": "500nM",
      "time": "24h"
    },
    "magnification": "20x",
    "outcome": "inconclusive",
    "notes": "Cell morphology assessment. 27 cells visible. Drug-treated cells show elongated morphology.",
    "quality_score": 0.88,
    "cell_count": 27,
    "experiment_date": "2025-05-13",
    "acquisition_date": "2025-05-14 08:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_012.png",
    "filename": "brightfield_012.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "IF-20260127-868",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "Phase Contrast",
    "cell_line": "U2OS",
    "treatment": "Rapamycin",
    "concentration": "100nM",
    "conditions": {
      "drug": "Rapamycin",
      "concentration": "100nM",
      "time": "12h"
    },
    "magnification": "10x",
    "outcome": "positive",
    "notes": "Cell morphology assessment. 40 cells visible. Some cells show rounded morphology suggesting stress.",
    "quality_score": 0.9,
    "cell_count": 40,
    "experiment_date": "2025-02-25",
    "acquisition_date": "2025-02-26 01:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_013.png",
    "filename": "brightfield_013.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "IF-20250917-184",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "DIC",
    "cell_line": "HEK293",
    "treatment": "DMSO",
    "concentration": "0.1%",
    "conditions": {
      "drug": "DMSO",
      "concentration": "0.1%",
      "time": "24h"
    },
    "magnification": "20x",
    "outcome": "negative",
    "notes": "Cell morphology assessment. 17 cells visible. Drug-treated cells show elongated morphology.",
    "quality_score": 0.83,
    "cell_count": 17,
    "experiment_date": "2025-04-10",
    "acquisition_date": "2025-04-11 17:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_014.png",
    "filename": "brightfield_014.png"
  },
  {
    "image_type": "microscopy",
    "experiment_id": "GEL-20250819-143",
    "experiment_type": "Brightfield Microscopy",
    "imaging_mode": "Brightfield",
    "cell_line": "THP-1",
    "treatment": "Crizotinib",
    "concentration": "250nM",
    "conditions": {
      "drug": "Crizotinib",
      "concentration": "250nM",
      "time": "6h"
    },
    "magnification": "20x",
    "outcome": "negative",
    "notes": "Cell morphology assessment. 31 cells visible. Increased cell density observed.",
    "quality_score": 0.83,
    "cell_count": 31,
    "experiment_date": "2025-11-01",
    "acquisition_date": "2025-11-02 18:40",
    "file_path": "C:\\Users\\28k\\Pictures\\dataoverflowwebsite\\lacoste\\lacoste001\\data\\images\\biological\\brightfield_015.png",
    "filename": "brightfield_015.png"
  }
]